Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Gastroenterology | Family Medicine
Clinical Trials: Vomiting
A listing of clinical trials currently looking for volunteers to enroll in Vomiting studies. Click on the closest city to find more detailed information on a research study in your area.
Alabama
Muscle Shoals : Northwest Alabama Cancer Center
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Muscle Shoals, : Northwest Alabama Cancer Center PC
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Arkansas
Hot Spring : Genesis Cancer Centre
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
California
Burbank : Providence St. Joseph Medical Center
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Corona : Compassionate Cancer Care Center Medical Group
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Fountain Valley : Compassionate Cancer Centre Medical Group
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Mission Hills : Facey Medical Foundation
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Orange : Call for Information (Investigational Site 0014)
A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208 AM3)
View More »
Palm Springs : Call for Information (Investigational Site 0021) Updated
Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-induced Nausea and Vomiting (MK-0517-031 AM3)
Riverside : Compassionate Cancer Care Medical Group
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
Riverside : Compassionate Cancer Care Medical Group
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Whittier : Agajanian Institute of Oncology and Hematology
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Colorado
Aurora : Call for Information (Investigational Site 0001)
A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134 AM3)
Denver : Denver Health and Hospital Authority
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
District of Columbia
Washington : Call for Information (Investigational Site 0041)
A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134 AM3)
Florida
Boynton Beach : Palm Beach Institute of Hematology and Oncology
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Jupiter : Call for Information (Investigational Site 0174) Updated
Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-induced Nausea and Vomiting (MK-0517-031 AM3)
Lakeland : Call for Information (Investigational Site 0035) Updated
Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-induced Nausea and Vomiting (MK-0517-031 AM3)
Miami : Call for Information (Investigational Site 0042)
A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134 AM3)
St. Petersburg : Call for Information (Investigational Site 0012)
A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208 AM3)
Indiana
Anderson : Call for Information (Investigational Site 9277) Updated
Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-induced Nausea and Vomiting (MK-0517-031 AM3)
Evansville : Welborn Clinic
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Evansville : Call for Information (Investigational Site 0020) Updated
Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-induced Nausea and Vomiting (MK-0517-031 AM3)
New Albany : Floyd Memorial Cancer Center of Indiana
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Iowa
Cedar Rapids : Call for Information (Investigational Site 0037) Updated
Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-induced Nausea and Vomiting (MK-0517-031 AM3)
Kentucky
Hazard : North Shore Medical Center
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Louisville : Call for Information (Investigational Site 0003)
A Study of Aprepitant (MK0869) in Pediatric Participants Undergoing Surgery (0869-148 AM1)
Maryland
Rockville : Call for Information (Investigational Site 0036) Updated
Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-induced Nausea and Vomiting (MK-0517-031 AM3)
Massachusetts
Boston : Call for Information (Investigational Site 0020)
A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134 AM3)
Boston : Call for Information (Investigational Site 0013)
A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208 AM3)
Waltham : TESARO Inc
A Safety and Efficacy Study of Rolapitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Subjects Receiving Highly Emetogenic Chemotherapy
Waltham : TESARO Inc
A Safety and Efficacy Study of Rolapitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Subjects Receiving Moderately Emetogenic Chemotherapy
Waltham : TESARO Inc
Phase 3 Safety and Efficacy Study of Rolapitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Subjects Receiving Highly Emetogenic Chemotherapy
View More »
Worcester : Fallon Clinic
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Missouri
St. Louis : Call for Information (Investigational Site 0043)
A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134 AM3)
New York
Bronx : Children's Hospital at Montefiore
A Randomized Trial of The Effectiveness of Aromatherapy on Chemotherapy Induced Nausea and Vomiting in Children With Cancer
North Carolina
Durham : Duke University Medical Center
Daily Tadalafil and Gastric Emptying Time in Diabetic Gastroparesis
Winston-Salem : Salem Research Group, Inc.
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Ohio
Canton : Hematology and Oncology Associates, Inc.
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Canton : Tri-County Hematology & Oncology Associates, Inc
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Pennsylvania
Pittsburgh : UPMC Magee Women's Hospital
Effectiveness of Aprepitant in the Treatment of Postoperative Nausea and Vomiting (PONV) in Patients Undergoing Outpatient Plastic Surgery
Rhode Island
Pawtucket : Cancer Center at Memorial Hospital of RI
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
South Carolina
Charleston : Charleston Cancer Center
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Columbia : Call for Information (Investigational Site 0031)
A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134 AM3)
Tennessee
Nashville : Call for Information (Investigational Site 0022)
A Study of Aprepitant (MK0869) in Pediatric Participants Undergoing Surgery (0869-148 AM1)
Texas
Corpus Christi : Cancer Specialists of South Texas, P.A.
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Houston : Call for Information (Investigational Site 0176) Updated
Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-induced Nausea and Vomiting (MK-0517-031 AM3)
Houston : UT MD Anderson Cancer Center
Fosaprepitant in Patients Receiving Ifosfamide-based Regimen
Temple : Scott and White Healthcare
Combination Antiemetic Regimen for Prevention of PONV in Breast Surgery Patients
Utah
Ogden : Northern Utah Associates [Hematology/ Oncology]
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
Ogden : Northern Utah Associates
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Washington
Seattle : Call for Information (Investigational Site 0032) Updated
Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-induced Nausea and Vomiting (MK-0517-031 AM3)
Spokane : Providence Sacred Heart Medical Center and Children's Hospital
Safety and Pharmacokinetics of Sancuso and IV Granisetron in Patients Aged 13 to 17 Years
Tacoma : Northwest Medical Specialties
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Tacoma : Call for Information (Investigational Site 9315) Updated
Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-induced Nausea and Vomiting (MK-0517-031 AM3)
Argentina
Buenos Aires : Merck Sharp & Dohme (Argentina) Inc.
A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208 AM3)
Cordoba : Instituto Oncológico de Córdoba (IONC)
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
Mar del Plata : Centro Oncológico Integral (COI)
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Mendoza : Centro Oncologico de Integracion Regional (COIR)
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Quilmes : Instituto Médico CER [Oncology]
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
View More »
Quilmes B1878DVB : Instituto Médico CER [Oncology]
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Rosario : Sanatorio Parque
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
Rosario : Sanatorio Parque
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
San Miguel de Tucuman : Centro Medico San Roque
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
San Miguel de Tucuman : Centro Medico San Roque
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Australia
Adelaide SA : RAH Cancer Centre, Royal Adelaide Hospital
Efficacy of Two Antiemetic Regimens in Patients Receiving Radiotherapy and Concomitant Weekly Cisplatin
South Granville : Merck Sharp & Dohme (Australia) Pty Ltd.
A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134 AM3)
Belarus
Bobruisk : Bobruisk Interregional Oncological Dispensary
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Brest : Brest Regional Oncological Dispensary
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Gomel : State institution N.N. Alexandrov Republican Scientific and
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Mogilev : Mogilev Regional Oncological Dispensary [Oncology]
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Brazil
Belo Horizonte : OXION-Medicina Oncológica
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Cachoeiro de Itapemirim : Centro de Pesquisas Clínicas em Oncologia
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Caxias do Sul : IPCEM - Universidade de Caxias do Sul
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Goiânia : Hospital Araújo Jorge
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
ItajaÃ- : ClÃ-nica de Neoplasias do Litoral
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
View More »
Porto Alegre : Hospital Moinhos de Vent
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Rio de Janeiro : Oncotrat Oncologia Medica Ltda [Oncology]
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Salvador : Nucleo de Oncologia da Bahia
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Sao Paulo : Merck Sharp & Dohme Farmaceutica Ltda.
A Study of Aprepitant (MK0869) in Pediatric Participants Undergoing Surgery (0869-148 AM1)
Sao Paulo : Merck Sharp & Dohme Farmaceutica Ltda.
A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134 AM3)
São Paulo : Hospital Santa Marcelina
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Bulgaria
Gabrovo : MHAT Dr. Tota Venkova [Oncology]
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
Gabrovo : MHAT Dr. Tota Venkova [Oncology]
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Haskovo : Inter District Dispensery with Stationary
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Pleven : UMHAT "Dr. Georgi Stranski"
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Pleven : UMHAT ""Dr. Georgi Stranski"" Dept. Medical Oncology
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
View More »
Plovdiv : UMHAT "Sveti Georgi" [Clinic of Oncology and Hematology]
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Sofia : District Dispensery for Oncology Diseases with in-patient
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
Sofia : District Dispensery with Stationary - Sofia District
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
Sofia : SHATO - Sofia
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
Sofia : UMHAT "Tsaritsa Yoanna - ISUL" Ltd.Medical Oncology Clinic
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
Sofia : SHATO - Sofia
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Sofia : UMHAT "Tsaritsa Yoanna - ISUL" Ltd.Medical Oncology Clinic
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Sofia : SHATOD - Sofia City
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Sofia : District Dispensery with Stationary - Sofia District
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Sofia : Merck Sharp & Dohme IDEA Inc. Updated
Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-induced Nausea and Vomiting (MK-0517-031 AM3)
Stara Zagora : Comprehensive Oncology Centre
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
Stara Zagora : Comprehensive Oncology Centre
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Tarnovo : Inter District Oncology Dispensary with In-patient Stationar
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Varna : IDDODS "Dr. Marko Markov", Base 2 [Dept. of Medicinal Onco
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Veliko Tarnovo : Inter District Oncology Dispensary with In-patient Stationar
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Vratsa : Comprehensive Cancer Center - Vratsa
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Vratsa : Comprehensive Cancer Center - Vratsa
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Canada
Kirkland : Merck Frosst Canada Ltd.
Fosaprepitant (EMEND® IV) In Salvage Treatment of Chemotherapy-Induced Vomiting (MK-0517-030 AM1)
Chile
Santiago : Merck Sharp & Dohme (I.A.) Corp.
A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208 AM3)
Colombia
Bogota : Frosst Laboratories Inc.
A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208 AM3)
Bogota : Frosst Laboratories Inc. Updated
Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-induced Nausea and Vomiting (MK-0517-031 AM3)
Croatia
Cakovec : Županijska bolnica Cakovec
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Osijek : Klinicki bolnicki centar [Oncology]
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
Osijek : Klinicki bolnicki centar Osijek [Oncology]
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Pula : Opca bolnica Pula [Odjel za onklologiju]
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Rijeka : KBC Rijeka [Gastroenterology]
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
View More »
Rijeka : KBC Rijeka [Gastroenterology]
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Varazdin : Opca bolnica Varazdin [Odjel za hem.onko i klin.imun.]
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
Varazdin : Opca bolnica Varazdin [Odjel za hem.onko i klin.imun.]
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Zadar : General Hospital Zadar
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Zagreb : Klinicka bolnica [Sestre milosrdnice]
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
Zagreb : Klinika za tumore [Odjel za kemoter. i internisticku onkolog
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Zagreb : Klinicka bolnica [Sestre milosrdnice]
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Zagreb : Klinički bolnički centar Zagreb [Oncology]
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Czech Republic
Mlada Boleslav : Oblastni nemocnice Mlada Boleslav a.s., Onkologie
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Nymburk : AVICENNUS s.r.o. Onkologie Nymburk
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Praha : Merck Sharp & Dohme IDEA Inc. Updated
Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-induced Nausea and Vomiting (MK-0517-031 AM3)
Praha 5 : Fakultni nemocnice v Motole
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Praha 5 : Nemocnice Na Homolce, Oddeleni klinicke onkologie
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
View More »
Znojmo : Nemocnice Znojmo, p.o.
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Denmark
Aarhus : Department of Oncology
Efficacy of Two Antiemetic Regimens in Patients Receiving Radiotherapy and Concomitant Weekly Cisplatin
Copenhagen : Rigshospitalet, Finsen Centret
Efficacy of Two Antiemetic Regimens in Patients Receiving Radiotherapy and Concomitant Weekly Cisplatin
Glostrup : Merck Sharp & Dohme
A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208 AM3)
Herlev : Herlev Hospital
Efficacy of Two Antiemetic Regimens in Patients Receiving Radiotherapy and Concomitant Weekly Cisplatin
Odense : Department of Oncology, Odense University Hospital
Efficacy of Two Antiemetic Regimens in Patients Receiving Radiotherapy and Concomitant Weekly Cisplatin
Dominican Republic
Santo Domingo : Merck Sharp & Dohme (IA) Corp.
A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208 AM3)
Ecuador
Quito : Merck Sharp and Dohme (I.A.) Corp. Ecuador
A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208 AM3)
Finland
Espoo : MSD Finland Oy Updated
Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-induced Nausea and Vomiting (MK-0517-031 AM3)
France
Courbevoie : Laboratoires Merck Sharp & Dohme - Chibret
A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134 AM3)
Germany
Augsburg : Praxis [Heinrich, Brudler, Bangerter-Haemato., Onko., Med. T
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Berlin : Medizinisches Versorgungszentrum für Hämatologie und Tumorerkrankungen, HIV/AIDS und Hepatitiden
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Berlin : Gynäkologische Arztpraxis
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Berlin : Vivantes Klinikum Neukolln
Efficacy of Two Antiemetic Regimens in Patients Receiving Radiotherapy and Concomitant Weekly Cisplatin
Dresden : Universitaetsklinikum Carl Gustav Carus
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
View More »
Duisburg : St. Johannes Hospital Medizinische Klinik II, Hämatologie, Onkologie und klinische Immunologie
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Haar : Msd Sharp & Dohme Gmbh
A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134 AM3)
Hamburg : OncoResearch Lerchenfeld UG
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
Hamburg : OncoResearch Lerchenfeld UG
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Hannover : Medizinische Hochschule, Zentrum für Innere Medizin, Klinik für Hämatologie, Hämostaseologie, Onkologie und Stammzelltransplantation
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Hennigsdorf : Ärzteforum Hennigsdorf
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Kiel : Universitatsklinikum Schleswig Holstein
Efficacy of Two Antiemetic Regimens in Patients Receiving Radiotherapy and Concomitant Weekly Cisplatin
Marburg : Praxis für Innere Medizin, Hämatologie und Internistische Onkologie
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Mönchengladbach : Kliniken Maria Hilf GmbH, Krankenhaus St. Franziskus
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
München : Städtisches Klinikum [Hämato-, Onkologie + Palliativmed]
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
München : Staedtisches Krankenhaus Muenchen Neuperlach
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
München : Rotkreuzklinikum [München]
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
München : Städtisches Klinikum [Hämato-, Onkologie + Palliativmed]
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
München : Staedtisches Krankenhaus Muenchen Neuperlach [Klinik fuer On
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Regensburg : Praxis Fuer Interdisziplinaere Onkologie und Haematologie
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Regensburg : OncoPRO GbR Dr. R. Dengler, Dr. A. Kröber Gesellschaft für klinische Studien in der ambulanten Hämatologie und Onkologie
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Tübingen : Universitätsklinikum Tübingen
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Velen : Zentrum für Onkologie
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Greece
Alimos : Vianex, S.A. / MSD
A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208 AM3)
Alimos : Vianex, S.A. / MSD Updated
Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-induced Nausea and Vomiting (MK-0517-031 AM3)
Hungary
Budapest : Országos Onkológiai Intézet [B. Belgyógyászati Osztály
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Budapest : MSD Magyarorszag Kft.
A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134 AM3)
Budapest : MSD Magyarorszag Kft.
A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208 AM3)
Budapest : Semmelweis Egyetem Kútvölgyi Klinikai Tömb [Onkohaemato
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
Budapest : Fővárosi Önkormányzat Uzsoki utcai Kórház
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
View More »
Budapest : Semmelweis Egyetem Kútvölgyi Klinikai Tömb [Onkohaemato
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Budapest : Fővárosi Önkormányzat Uzsoki utcai Kórház [Onkoradiol
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Budapest : MSD Magyarorszag Kft. Updated
Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-induced Nausea and Vomiting (MK-0517-031 AM3)
Budapest : MSD Magyarorszag Kft. Updated
Study of the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Fosaprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Children Under 18 Years of Age (MK-0517-029 AM3)
Györ : Petz Aladár Megyei Oktató Kórház [Onkoradiológiai Oszt
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
Gyula : Bekes Megyei Kepviselo-testulet Pandy Kalman Korhaz [Megyei
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Kecskemet : Bács-Kiskun Megyei Önkormányzat Kórháza, Szegedi
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Miskolc : Borsod-Abaúj-Zemplén Megyei Kórház és Egyetemi Oktatók
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Miskolc : Borsod-Abaúj-Zemplén Megyei Kórház és Egyetemi Oktató Kórház
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Nyíregyháza : Josa Andras Oktato Korhaz [Onkologiai Osztaly]
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Pécs : Pécsi Tudományegyetem [Onkoterápiás Intézet]
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
Pécs : Pécsi Tudományegyetem [Onkoterápiás Intézet]
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Szentes : Dr. Bugyi Istvan Korhaz [Oncology]
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Szolnok : Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz [Onkologiai
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
Szolnok : Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz [Onkologiai
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
India
Ahmedabad : M.S Patel Cancer Hospital [Oncology]
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Ahmedabad : Vedanta Hospital [Medical Oncology]
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Ahmedabad : HCG - Medi Surge Hospitals [Medical Oncology]
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Amravati : Sujan Surgical Cancer Hospital and Amracvati Cancer Foundati
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
Amravati : Sujan Surgical Cancer Hospital and Amracvati Cancer Foundati
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
View More »
Bangalore : Sri Venkateshwara Hospital [Medical Oncology]
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
Bangalore : Sri Venkateshwara Hospital [Medical Oncology]
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Chennai : Dr.Rai Memorial Medical centre
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Chennai : Apollo Hospitals [Oncology]
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
Chennai : Apollo Hospitals [Oncology]
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Chennai : Dr. Kamahshi Memorial Hospital [Oncology]
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Cuttack : Acharya Harihara Regional Cancer Centre [Oncology]
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Hubli : Research Unit, The Karnatak cancer therapy & Research Instit
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Hyderabad : Yashoda Super speciality Hospital [Medical Oncology]
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
Hyderabad : BIBI General Hospital & Cancer Centre [Oncology]
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Hyderabad : Yashoda Super speciality Hospital [Medical Oncology]
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Jaipur : S.M.S College And Hospital
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Kolkata : B.P.Poddar Hospital [Medical Oncology]
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Kolkata : Apollo Gleneagles Hospital [Clinical Trial and Research]
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Lucknow : Lucknow Cancer Institute [Oncology]
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Nashik : Sotabdi Super Speciality Hospital
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Pune : Ruby Hall Hospital [Oncology]
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Vijayawada : City Cancer Centre [Surgical and Medical Oncology]
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
Vijayawada : City Cancer Centre [Surgical and Medical Oncology]
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Visakhapatnam : King George Hospital [Medical Oncology]
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Israel
Hod Hasharon : Merck Sharp & Dohme Co. Ltd.
A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208 AM3)
Italy
Brescia : Fondazione Poliambulanza Istituto Ospedaliero [U.O. di Onco
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
Brescia : Fondazione Poliambulanza Istituto Ospedaliero [U.O. di Onco
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Lecce : ASL di Lecce-P.O.Vito Fazzi[U.O. di Oncologia Medica]
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
Lecce : ASL di Lecce-P.O.Vito Fazzi[U.O. di Oncologia Medica]
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Lecco : Presidio Ospedaliero "Alessandro Manzoni"(Struttura
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
View More »
Lecco : Presidio Ospedaliero "Alessandro Manzoni"(Struttura
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Milan : Merck Sharp & Dohme (Italia) S.P.A.
A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208 AM3)
Negrar : Ospedale Sacro Cuore e Don Calabria - Negrar [Oncologia Medi
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Potenza : Ospedale S.Carlo di Potenza [U.O. di Oncologia Medica]
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
Japan
Hidaka : Research site
Phase II Study of SyB D-0701 for Radiotherapy-Induced Nausea and Vomiting (RINV)
Kashihara : Research site
Phase II Study of SyB D-0701 for Radiotherapy-Induced Nausea and Vomiting (RINV)
Kashiwa : Research site
Phase II Study of SyB D-0701 for Radiotherapy-Induced Nausea and Vomiting (RINV)
Koshigaya : Research Site
Phase II Study of SyB D-0701 for Radiotherapy-Induced Nausea and Vomiting (RINV)
Kyoto : Research
Phase II Study of SyB D-0701 for Radiotherapy-Induced Nausea and Vomiting (RINV)
View More »
Maebashi : Research site
Phase II Study of SyB D-0701 for Radiotherapy-Induced Nausea and Vomiting (RINV)
Nagoya : Research site
Phase II Study of SyB D-0701 for Radiotherapy-Induced Nausea and Vomiting (RINV)
Nakagami : Research site
Phase II Study of SyB D-0701 for Radiotherapy-Induced Nausea and Vomiting (RINV)
Niigata : Research site
Phase II Study of SyB D-0701 for Radiotherapy-Induced Nausea and Vomiting (RINV)
Ota : Research site
Phase II Study of SyB D-0701 for Radiotherapy-Induced Nausea and Vomiting (RINV)
Sagamihara : Research site
Phase II Study of SyB D-0701 for Radiotherapy-Induced Nausea and Vomiting (RINV)
Sapporo : Research site
Phase II Study of SyB D-0701 for Radiotherapy-Induced Nausea and Vomiting (RINV)
Sayama : Research site
Phase II Study of SyB D-0701 for Radiotherapy-Induced Nausea and Vomiting (RINV)
Tokyo : Reseach site
Phase II Study of SyB D-0701 for Radiotherapy-Induced Nausea and Vomiting (RINV)
Tokyo : Research site
Phase II Study of SyB D-0701 for Radiotherapy-Induced Nausea and Vomiting (RINV)
Yamagata : Research site
Phase II Study of SyB D-0701 for Radiotherapy-Induced Nausea and Vomiting (RINV)
Yokohama : Research site
Phase II Study of SyB D-0701 for Radiotherapy-Induced Nausea and Vomiting (RINV)
Korea, Republic of
Seoul : MSD Korea Ltd.
A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208 AM3)
Seoul : Seoul St. Mary's Hospital
Phase 4 Trial to Evaluate the Efficacy and Safety of Sancuso Patch in Chemotherapy-induced Nausea and Vomiting Associated With the Administration of Highly Emetogenic Chemotherapy (HEC)
Seoul : Samsung Medical Center
Phase 4 Trial to Evaluate the Efficacy and Safety of Sancuso Patch in CINV (Chemotherapy-induced Nausea and Vomiting) Associated With the Administration of MEC (Moderately Emetogenic Chemotherapy)
Seoul : Kangpook Samsung Hospital
Therapeutic Efficacy and Safety of Palonosetron in Treatment of Postoperative Nausea and Vomiting
Seoul : Sangye Bahk Hospital, Inje School of Medicine
Therapeutic Efficacy and Safety of Palonosetron in Treatment of Postoperative Nausea and Vomiting
View More »
Seoul : Bungdang Seoul National University Hospital
Therapeutic Efficacy and Safety of Palonosetron in Treatment of Postoperative Nausea and Vomiting
Seoul : Samsung Medical Center
Therapeutic Efficacy and Safety of Palonosetron in Treatment of Postoperative Nausea and Vomiting
Latvia
Riga : Merck Sharp & Dohme Idea Inc Updated
Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-induced Nausea and Vomiting (MK-0517-031 AM3)
Lithuania
Vilnius : UAB Merck Sharp & Dohme
A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208 AM3)
Mexico
Chihuahua : Centro Estatal de Oncologia de Chihuahua
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Mexico : Centro Medico Quirurgico
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Mexico City : Merck Sharp & Dohme De Mexico, S.A. De C.V.
A Study of Aprepitant (MK0869) in Pediatric Participants Undergoing Surgery (0869-148 AM1)
Mexico City : Merck Sharp & Dohme De Mexico, S.A. De C.V.
A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134 AM3)
Mexico City : Merck Sharp & Dohme De Mexico, S.A. De C.V.
A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208 AM3)
View More »
Monterrey : Centro Regiomontano de Investigación Clínica
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Netherlands
Haarlem : Merck Sharp & Dohme B.V.
A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208 AM3)
Haarlem : Merck Sharp & Dohme B.V. Updated
Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-induced Nausea and Vomiting (MK-0517-031 AM3)
Norway
Drammen : MSD (Norge) AS
A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134 AM3)
Drammen : MSD (Norge) AS Updated
Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-induced Nausea and Vomiting (MK-0517-031 AM3)
Oslo : The Norwegian Radium Hospital
Efficacy of Two Antiemetic Regimens in Patients Receiving Radiotherapy and Concomitant Weekly Cisplatin
Peru
Lima : Merck Sharp & Dohme, Peru S.R.L.
A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134 AM3)
Lima : Merck Sharp & Dohme, Peru S.R.L.
A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208 AM3)
Poland
Bialystok : Bialostockie Centrum Onkologii im. M.Sklodowskiej-Curie
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Bialystok : Bialostockie Centrum Onkologii im. M.Sklodowskiej-Curie
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Elblag : Szpital Wojewodzki Zespolony
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
Koscierzyna : Niepubliczny Specjalist. Onkol. Zaklad Opieki Zdrowotnej
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Lodz : Wojewodzki Szpital Specjalistyczny im. M.Kopernika
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
View More »
Lodz : Wojewodzki Szpital Specjalistyczny im. M.Kopernika
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Lomza : Szpital Wojewodzki w Lomzy im. Kardynala S. Wyszynskiego
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
Lomza : Szpital Wojewodzki w Lomzy im. Kardynala S. Wyszynskiego
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Lublin : Centrum Onkologii Ziemi Lubelskiej im.Sw.Jana z Dukli
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Olsztyn : Olsztynski Osrodek Onkologiczny "KOPERNIK"
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Poznan : Ginekologiczno-Położniczy Szpital Kliniczny UM w Poznaniu
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Poznan : Wielkopolskie Centrum Onkologii im. M. Sklodowskiej-Curie
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Prabuty : Szpital Specjalistyczny
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Raciborz : Szpital Rejonowy im. dr J. Rostka w Raciborzu
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Raciborz : Szpital Rejonowy im. dr J. Rostka w Raciborzu
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Slupsk : Wojewodzki Szpital Specjalistyczny im. J. Korczaka
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
Slupsk : Wojewodzki Szpital Specjalistyczny im. J. Korczaka
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Warszawa : MSD Polska Sp. z o.o. Dzial Medyczny
A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134 AM3)
Warszawa : MSD Polska Sp. z o.o. Dzial Medyczny
A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208 AM3)
Warszawa : NZOZ Magodent - Centrum Medczyne Ostrobramska
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
Warszawa : Centrum Onkologii - Instytut im. Marii Sklodowskiej - Curie
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
Warszawa : NZOZ Magodent - Centrum Medczyne Ostrobramska
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Warszawa : MSD Polska Sp. z o.o. Dzial Medyczny Updated
Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-induced Nausea and Vomiting (MK-0517-031 AM3)
Portugal
Paco D`arcos : Merck Sharp & Dohme Lda Updated
Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-induced Nausea and Vomiting (MK-0517-031 AM3)
Romania
Baia-Mare : Spitalul Judetean de Urgenta "Dr. Constantin Opris" [Oncolog
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
Baia-Mare : Spitalul Judetean de Urgenta "Dr. Constantin Opris" Baia-Mare [Oncologie Medicala]
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Bucharest : Institutul Oncologic "Prof. Dr. Alex. Trestioreanu" [Sectia
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
Bucuresti : Spitalul Universitar de Urgenta Bucuresti [Oncologie Medical
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Bucuresti : Spitalul Clinic CF nr.2 Bucuresti [Oncologie Medicala]
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
View More »
Bucuresti : Institutul Oncologic "Prof. Dr. Alex. Trestioreanu" [Sectia Clinica Radioterapie II]
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Bucuresti : Spitalul Universitar de Urgenta Elias [Oncologie Medicala]
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Cluj-Napoca : Institutul Oncologic "Prof. Dr. Ion Chiricuta"
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
Craiova : Oncolab - Oncology Center Craiova
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Iasi : Spitalul Clinic Judetean de Urgenta "Sf. Spiridon" [Oncologi
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
Iasi : Centrul de Oncologie Euroclinic SRL
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
Iasi : Spitalul Clinic Judetean de Urgenta "Sf. Spiridon" [Oncologi
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Onesti : Spitalul Municipal Onesti [Sectia Oncologie Medicala]
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Sibiu : Spitalul Clinic Judetean de Urgenta Sibiu [Oncologie]
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Tg Mures : Spitalul Clinic Judetean Mures [Clinica de Oncologie Medical
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Timisoara : Oncomed SRL
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
Timisoara : Oncomed SRL
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Russian Federation
Arkhangelsk : GUZ Arkhangelsk Regional Clinical Oncological Dispensary [Ch
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
Arkhangelsk : GUZ Arkhangelsk Regional Clinical Oncological Dispensary [Ch
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Chelyabinsk : GLPU "Cheliabinsky Regional Oncology Dispensary"[Chemotherap
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Ivanovo : Ivanovo Regional Oncological Dispensary [Chemotherapy]
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Kazan : Clinical Oncology Dispensary
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
View More »
Kazan : Clinical Oncology Dispensary [Chemotherapy]
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Krasnoyarsk : GOU VPO Krasnoyarsk State Medical University n.a. prof. V.F.
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
Krasnoyarsk : GOU VPO Krasnoyarsk State Medical University n.a. prof. V.F.
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Lipetsk : GUZ Lipetsk Regional Oncology Dispensary [General Oncology]
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Magnitogorsk : GUZ Regional Oncology Dispensary #2
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
Magnitogorsk : GUZ Regional Oncology Dispensary #2
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Moscow : Merck Sharp & Dohme IDEA, Inc.
A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208 AM3)
Moscow : Russian Cancer Research Center
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
Moscow : Russian Oncology Research Center n.a. N.N. Blokhin RAMN
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
Moscow : SHI of Moscow City Oncology Clinical Hospital #62 [Chemotera
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Moscow : Russian Cancer Research Center
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Novgorod : Federal State Institution: Privolzhsky County Medical Center
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Novosibirsk : MBUZ City Clinical Hospital #1 [Oncology]
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
Novosibirsk : MBUZ City Clinical Hospital #1 [Oncology]
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Obninsk : Institution of RAMN "Medical Radiology Scientific Center of
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
Obninsk : Institution of RAMN "Medical Radiology Scientific Center of
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Orel : Regional Oncological Dispensary [Chemotherapy]
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Perm : GUZ Perm Regional Oncology Dispensary [Outpatient department
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Pyatigorsk : GUZ Pyatigorsk Oncology Dispensary [Outpatient Department]
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Ryazan : Ryazan State Med. Univer. n.a. I.I.Pavlov based Ryazan Regio
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Saint Petersburg : St. Petersburg Clinical Oncology Dispesary [3rd Gynecology D
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
Saint Petersburg : GUZ Leningrad Regional Oncological Dispensary [Surgery Depar
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
Saint Petersburg : GOU VPO Saint-Petersburg State Medical University n.a. acad.
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Saint Petersburg : St. Petersburg Clinical Oncology Dispesary [3rd Gynecology D
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Saint Petersburg : City Oncology Dispensary
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Saint-Petersburg : GOU VPO "Saint-Petersburg State Medical University
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Saint-Petersburg : GUZ "Leningrad Regional Oncology Dispensary" [mammological d
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Samara : GUZ Samara Regional Clinical Oncology Dispensary [Chemoterap
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Stavropol : Stavropol Regional Clinical Oncology Dispensary
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Tula : GUZ Tula Regional Oncological Dispensary [Oncology]
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Tyumen : GUZ Leningradskiy Regional Oncology Dispensary
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Ufa : Clinical Oncology Dispensary
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Ufa : Clinical Oncology Dispensary [Oncology]
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Ufa : GUZ Republican Clinical Oncological Dispensary of public
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Serbia
Beograd : Institute of oncology and radiology of Serbia
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Beograd : Clinical Hospital Center Bezanijska Kosa
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Kragujevac : Clinical Center Kragujevac
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Slovenia
Ljubljana : Merck Sharp & Dohme Idea, Inc
A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208 AM3)
Spain
Madrid : Merck Sharp & Dohme De Espana, S.A.E.
A Study of Aprepitant (MK0869) in Pediatric Participants Undergoing Surgery (0869-148 AM1)
Madrid : Merck Sharp & Dohme De Espana, S.A.E.
A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134 AM3)
Madrid : Merck Sharp & Dohme De Espana, S.A.E.
A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208 AM3)
Madrid : Merck Sharp & Dohme De Espana, S.A.E. Updated
Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-induced Nausea and Vomiting (MK-0517-031 AM3)
Madrid : Merck Sharp & Dohme De Espana, S.A.E. Updated
Study of the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Fosaprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Children Under 18 Years of Age (MK-0517-029 AM3)
Sweden
Sollentuna : Merck Sharp & Dohme (Sweden) AB
A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134 AM3)
Sollentuna : Merck Sharp & Dohme (Sweden) AB
A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208 AM3)
Sollentuna : Merck Sharp & Dohme (Sweden) AB Updated
Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-induced Nausea and Vomiting (MK-0517-031 AM3)
Switzerland
Glattbrugg : Merck Sharp & Dohme - Chibret, A.G.
A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134 AM3)
Turkey
Istanbul : Merck Sharp & Dohme Ilaclari Ltd. Sti
A Study of Aprepitant (MK0869) in Pediatric Participants Undergoing Surgery (0869-148 AM1)
Istanbul : Merck Sharp & Dohme Ilaclari Ltd. Sti
A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208 AM3)
Ukraine
Cherkasy : Cherkaskyi oblasnyi onkolohichnyi dyspanser" Cherkaskoi obl
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Chernigiv : Komunalnyi likuvalno-profilaktychnyi zaklad "Chernigivskyi
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Chernivtsi : Chernivtsi Regional Cancer Hospital [Outpatient Department]
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Dnipropetrovks : MBKL4,vd khimter,DDMA,kf onko i med radio [vd khimter]
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Dnipropetrovks : MBKL4,vd khimter,DDMA,kf onko i med radio [vd khimter]
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
View More »
Dnipropetrovsk : KZ MKL19, MOTsr, vd khimter [viddilennia khimioterapii]
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Dnipropetrovsk : Komunalnyi zaklad Miska bahatoprofilna klinichna likarnia #4
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
Donetsk : KKLPZ DnOPTsr [radio vd]
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Donetsk : Komunalno-klinichnyi likuvalno-profilaktychnyi
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
Donetsk : Komunalno-klinichnyi likuvalno-profilaktychnyi zaklad "Done
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
Donetsk : Regional Oncological Hospital [Oncology/Pre-Tumor Diseases]
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Kharkiv : DU IMR AMNU [vd khemter]
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Kharkiv : DU IMR AMNU [vd khemter]
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
Kharkiv : Kharkivskyi oblasnyi onkologichnyi klinichnyi tsentr
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
Kharkiv : Kharkivskyi oblasnyi onkologichnyi klinichnyi tsentr
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Kyiv : KZ KOR Kyivskyi oblasnyi onkologichnyi dyspanser, [vid
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Lviv : Lvivskyi derzhavnyi onkologichnyi regionalnyi likuvalno-diag
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Odessa : Odeska oblasna klinichna likarnia
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Poltava : PoOKOD PoOR [vd khimter] VDNZ UMSA,kf onko
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Poltava : PoOKOD PoOR [vd khimter] VDNZ UMSA,kf onko
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Uzhgorod : Zakarpatskyi oblasnyi klinichnyi onkodyspanser [viddilennia
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Uzhgorod : Uzhgorod National University [Oncology]
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
Uzhgorod : Zakarpatskyi oblasnyi klinichnyi onkodyspanser [viddilennia
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Zaporizhia : ZaOKOD [abdom vd]
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
United Kingdom
Hoddesdon : Merck Sharp & Dohme Ltd.
A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208 AM3)